Q3 2020

Filed May 15, 2020 · 10-Q · 45 days after period end · 0001104659-20-062716

Q3 2020 · 10-Q

Revenue

$96.00K

−81.8% vs Q3 2019

Net Income

-$4.68M

N/M vs Q3 2019

EPS Diluted

-$0.06

N/M vs Q3 2019

Gross Profit$10,000—

Operating Income

Same quarter

Metric	Q3 2020	Q3 2019	Q3 2018	Q3 2017
Revenue	$96.00K	$527.00K	$78.00K	$37.00K
Net Income	-$4.68M	-$4.22M	-$3.96M	-$3.91M
EPS Diluted	-$0.06	-$0.22	-$0.35	-$0.04

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

iBio, Inc. · CIK 1420720 · Engraved from SEC EDGAR